Skip to content

Effect of Blood Flow Restriction Therapy on Shoulder Muscle Strength in Patients with Subacromial Impingement Syndrome

Effect of Blood Flow Restriction Therapy on Shoulder Muscle Strength in Patients with Subacromial Impingement Syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060752
Enrollment
Unknown
Registered
2022-06-09
Start date
2022-06-10
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subacromial Impingement Syndrome

Interventions

BFR group:Exercise Therapy with BFR
Normal exercise group:Normal exercise therapy
Health group:None

Sponsors

Beijing Sport Univercity
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: SIS group: 1. Aged 18-35 years; 2. People with repetitive overhead movements; 3. Shoulder pain mainly on one side ( >12 weeks); 4. There were at least two findings: pain arc (60-120 degrees), positive impingemnet sign (Hawkins or Neer's test), pain or weak resistance to external rotation of shoulder or resistance to lifting of scapular plane; 5. Musculoskeletal ultrasound differential diagnosis of SIS. Healthy group: 1. People with repetitive overhead movements; 2. Sex, age (18-35 years old), height (±10 cm), weight (±15 kg), dominant hand and sport were matched with an SIS participant; 3. Both shoulder joints are healthy, without pain, trauma, surgery, limited functional activity.

Exclusion criteria

Exclusion criteria: 1. With medical complications, including pregnancy, diabetes, and rheumatoid arthritis; 2. Shoulder osteoarthritis, frozen shoulder; 3. The current diagnosis and/or previous glenohumeral joint relaxation or dislocation; 4. Rotator cuff tear, arm drop test positive, labrum injury; 5. Upper limb fracture, such as scapula, clavicle or humerus; 6. Had corticosteroids injection, oral non-steroidal anti-inflammatory drugs, drugs affecting muscle metabolism during the past six months; 7. Peripheral nerve injury and malignant tumor; 8. Shoulder symptoms originating in the spine; 9. Received shoulder strap and upper limb surgery within the past year; 10. Those who have not signed informed consent.

Design outcomes

Primary

MeasureTime frame
Isokinetic strength;Visual analogue scale (VAS);shoulder Iso-Max strength;

Secondary

MeasureTime frame
Shoulder pain and disability index (SPADI);Shoulder range of motioner;Surface electromyogram of shoulder; Musculoskeletal ultrasound data;

Countries

China

Contacts

Public ContactNi Guoxin

Beijing Sport Univercity

niguoxin@bsu.edu.cn+86 18612254389

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026